COL11A1 and intraductal breast papilloma: To conclude, the expression of COL11A1 in breast intraductal papillomas is an optimal prognostic biomarker, and we propose that patients with positive staining for this protein should be given further evaluation of both surgical treatment and preventive adjuvant chemotherapy.